Investigation of an Optimum Dosing Method of Levofloxacin 500 mg in Patients receiving Hemodialysis
Not Applicable
- Conditions
- bacterial infection
- Registration Number
- JPRN-UMIN000004077
- Lead Sponsor
- iigata University Medical & Dental Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients hypersensitive to quinolones. Pregnant women or women of child bearing potential. Children under 18 years old. Patients with liver cirrhosis. Blood albumin level is 3g/dl or less. Patients receiving preparations containing iron, magnesium or aluminum with some particular methods; Patients whose weight is less than 40 kg; Patients with infection which is already known that the pathogen is unresponsive to LVFX, and the bacterial strain is clinically evidently ineffective; Other patients judged by the investigator or the sub-investigator as inappropriate for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method